Penn Medicine: Yentli Soto Albrecht, PhD at ADPD 2026

Penn Medicine, University of Pennsylvania Health System · LinkedIn

Yentli Soto Albrecht, PhD is an MD–PhD in training, a genetic carrier 95% likely to get ALS and FTD in the next few decades, and a patient advocate working to change her own future and the lives of others. With support from Penn, she’s advancing powerful collaborations — from mapping proteins at a European lab facility to creating the first biorepository of stem cells with her genetic mutation.

For Yentli, conferences like AD/PD are more than a step in her training. They’re where Penn’s support meets her determination to turn a devastating diagnosis into science that could change what survival looks like.

View the post and watch the video here